DOV vs TECH · P/E 27, rev $7.75B vs P/E 65, rev $1.22B
Dover Corporation (DOV) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Dover Corporation (DOV) is a specialty industrial machinery company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported DOV revenue for 2024-12-31 was $7.75B. Net income was $2.70B. Revenue was up 0.8% from 2023-12-31 to 2024-12-31. DOV currently screens at market cap $28.92B and trailing P/E 26.8.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
DOV currently screens at market cap $28.92B and trailing P/E 26.8. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the DOV and TECH stock pages for the full models.
Not investment advice.